ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Q: What does CUSIP 82835W108 represent in this 13F holders report?

CUSIP 82835W108 is the security identifier for SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q1 2021?

67 institutional investors reported SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 82835W108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 98,600,500
Total 13F shares: 27,691,694
Share change: +3,246,039
Total reported value: $1,205,836,321
Price per share: $43.63
Number of holders: 67
Value change: +$139,058,596
Number of buys: 39
Number of sells: 35

Quarterly Holders Quick Answers

What is CUSIP 82835W108?
CUSIP 82835W108 identifies SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 82835W108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	8.9%	8,740,887	$405,053,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	3.5%	3,441,304	$155,810,000	—	31 Dec 2020	13F
EcoR1 Capital, LLC	13F	Company	2.6%	2,533,635	$117,409,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.8%	1,742,186	$80,733,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	1.7%	1,675,377	$77,637,000	—	31 Dec 2020	13F
Nantahala Capital Management, LLC	13F	Company	1.2%	1,206,471	$54,384,000	—	31 Dec 2020	13F
Cormorant Asset Management, LP	13F	Company	0.51%	500,000	$23,170,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.43%	428,714	$19,841,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0.4%	390,161	$18,081,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.35%	341,473	$15,824,000	—	31 Dec 2020	13F
Logos Global Management LP	13F	Company	0.3%	300,000	$13,902,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.24%	238,095	$11,033,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.22%	215,536	$9,988,000	—	31 Dec 2020	13F
WASATCH ADVISORS LP	13F	Company	0.21%	209,695	$9,717,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.2%	200,008	$9,268,000	—	31 Dec 2020	13F
PFM Health Sciences, LP	13F	Company	0.19%	188,243	$8,723,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.18%	174,261	$8,075,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.17%	166,039	$7,694,000	—	31 Dec 2020	13F
VR Adviser, LLC	13F	Company	0.15%	150,000	$6,951,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.14%	138,138	$6,401,000	—	31 Dec 2020	13F
Ally Bridge Group (NY) LLC	13F	Company	0.13%	128,572	$5,958,000	—	31 Dec 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.13%	125,000	$5,793,000	—	31 Dec 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.12%	116,037	$5,377,000	—	31 Dec 2020	13F
Soleus Capital Management, L.P.	13F	Company	0.11%	107,826	$4,997,000	—	31 Dec 2020	13F
Commodore Capital LP	13F	Company	0.1%	97,143	$4,502,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.09%	87,813	$4,069,000	—	31 Dec 2020	13F
GREAT POINT PARTNERS LLC	13F	Company	0.07%	70,000	$3,244,000	—	31 Dec 2020	13F
Monashee Investment Management LLC	13F	Company	0.06%	60,000	$2,780,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0.06%	58,788	$2,724,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.06%	57,575	$2,668,026	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	0.05%	50,000	$2,316,000	—	31 Dec 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.05%	47,620	$2,207,000	—	31 Dec 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.05%	45,000	$2,085,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.04%	42,680	$1,978,000	—	31 Dec 2020	13F
Pinz Capital Management, LP	13F	Company	0.04%	40,300	$1,868,000	—	31 Dec 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.04%	35,750	$1,657,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.03%	25,000	$1,159,000	—	31 Dec 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.03%	25,000	$1,159,000	—	31 Dec 2020	13F
Samsara BioCapital, LLC	13F	Company	0.03%	25,000	$1,159,000	—	31 Dec 2020	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0.02%	21,740	$1,007,000	—	31 Dec 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.02%	20,882	$968,000	—	31 Dec 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.02%	19,484	$903,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	19,230	$891,000	—	31 Dec 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	19,038	$882,000	—	31 Dec 2020	13F
CITIGROUP INC	13F	Company	0.02%	15,084	$699,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.01%	13,837	$641,000	—	31 Dec 2020	13F
SG Americas Securities, LLC	13F	Company	0.01%	12,900	$598,000	—	31 Dec 2020	13F
Tibra Equities Europe Ltd	13F	Company	0.01%	12,900	$598,000	—	31 Dec 2020	13F
MIRABELLA FINANCIAL SERVICES LLP	13F	Company	0.01%	11,340	$525,000	—	31 Dec 2020	13F
Janney Montgomery Scott LLC	13F	Company	0.01%	10,957	$508,000	—	31 Dec 2020	13F

Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q1 2021

As of 31 Mar 2021, ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,691,694 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, EcoR1 Capital, LLC, RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, Nantahala Capital Management, LLC, Cormorant Asset Management, LP, and AMERIPRISE FINANCIAL INC. This page lists 67 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.